Dr. Reddy’s API Participates in 2022 ANVISA Regulatory Symposium

API Solutions

Dr. Reddy's API business supplies high-quality, affordable APIs to leading generic formulations manufacturers and is the preferred API partner for pharma companies in more than 100 countries.

R&D

Dr. Reddy’s supplies generic APIs to 80+ countries, excelling in R\&D across niche molecules and key therapies, with capabilities from lab to production in contained/non-contained APIs and advanced chemical processes.

White Paper

Dr. Reddy’s offers insightful whitepapers sharing expertise on APIs, formulations, regulatory trends, and industry innovations, helping global pharma partners gain knowledge, solve challenges, and drive faster, compliant product development.

Dr. Reddy's API participated in the 2022 Pharmaceutical Industry and Regulators Symposium at ANVISA

Mr. Simão Correa da Silva, our Head of Regulatory Affairs, LATAM, participated in the round table discussion on ICH M7 and the assessment of the nitrosamines at the 2022 Pharmaceutical Industry and Regulators Symposium at ANVISA.

View More News

Contact Us

Phone

Quick Connect Send a message

API Solutions

R&D

White Paper

Dr. Reddy's API participated in the 2022 Pharmaceutical Industry and Regulators Symposium at ANVISA

Dr. Reddy's API participated in the 2022 Pharmaceutical Industry and Regulators Symposium at ANVISA

Contact Us

OR

Disclaimer: Products under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act (Bolar Exemption) and not for commercial sale.

Dr. Reddy's API participated in the 2022 Pharmaceutical Industry and Regulators Symposium at ANVISA

Dr. Reddy's API participated in the 2022 Pharmaceutical Industry and Regulators Symposium at ANVISA

Contact Us

OR